 ?您的位置：對(duì)照品 > 對(duì)照品 > 對(duì)照藥材 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：C192755 |
| 產(chǎn)品名稱：(S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4- |
| 產(chǎn)品CAS： |
| 規(guī)格含量：2.5mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
C192755 |
| 名稱: |
(S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-ynamide |
| 分子式: |
C??H??ClFN?O? |
| 分子量: |
483.92 |
| 類別: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
(S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-ynamide is an intermediate in the synthesis of (2Z)-Afatinib (A355305), which is a structural analogue of Afatinib (A355300), an aminocrotonylamino-substituted quinazoline derivative used for treating cancer and diseases of the respiratory tract, lungs, gastrointestinal tract, bile duct, and gallbladder. |
| 參考文獻(xiàn) |
|
|
|
|
|
|
